http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1139101-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9779afa74a3c3f6ff93275907bfe44f3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4737
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-686
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1b94796bd915e7f7abc5ba6a91ca94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_100f9095d493f618a55d0ad13d287e43
publicationDate 2002-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1139101-A9
titleOfInvention Immunoassay for c-reactive protein
abstract The present invention relates to new CRP immunoassayncompositions. The compositions include a low affinitynanti-human CRP monoclonal antibody, and an antiidiotypicnantibody raised against it. The invention furthernprovides a method for obtaining antiidiotypic monoclonalnantibody populations directed to an antibody that isnspecific for a high concentration, high molecular weightntarget antigen.
priorityDate 2000-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19094
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410600
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396842
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02741
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID751795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11801
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02742
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92452
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129721016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12245
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49254
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12944
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19062

Total number of triples: 61.